Ryohei Miyamoto, Akinari Sekine, T. Fujimaru, Tatsuya Suwabe, H. Mizuno, E. Hasegawa, M. Yamanouchi, Motoko Chiga, Takayasu Mori, E. Sohara, S. Uchida, N. Sawa, Y. Ubara, J. Hoshino
{"title":"常染色体显性多囊肾病的超声心动图表现和基因型","authors":"Ryohei Miyamoto, Akinari Sekine, T. Fujimaru, Tatsuya Suwabe, H. Mizuno, E. Hasegawa, M. Yamanouchi, Motoko Chiga, Takayasu Mori, E. Sohara, S. Uchida, N. Sawa, Y. Ubara, J. Hoshino","doi":"10.1159/000520300","DOIUrl":null,"url":null,"abstract":"Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary cystic kidney disease and is well known to have extrarenal complications. Cardiovascular complications are of particular clinical relevance because of their morbidity and mortality; however, unclear is why they occur so frequently in patients with ADPKD and whether they are related to the genotypes. Methods: We extracted and retrospectively analyzed clinical data on patients with ADPKD who underwent echocardiography and whose genotype was confirmed by genetic testing between April 2016 and December 2020. We used next-generation sequencing to compare cardiac function, structural data, and the presence of cardiac valvular disease in patients with 1 of 3 genotypes: PKD1, PKD2, and non-PKD1, 2. Results: This retrospective study included 65 patients with ADPKD. Patients were divided into 3 groups: PKD1, n = 32; PKD2, n = 12; and non-PKD1, 2, n = 21. The prevalence of mitral regurgitation (MR) was significantly higher in the PKD1 group than in the PKD2 and non-PKD1, 2 group (46.9% vs. 8.3% vs. 19.0%, respectively; p = 0.02). In contrast, no significant difference was found for other cardiac valve complications. Conclusion: This study found a significantly higher prevalence of MR in patients with the PKD1 genotype than in those with the PKD2 or non-PKD1, 2 genotypes. Physicians may need to perform echocardiography earlier and more frequently in patients with ADPKD and the PKD1 genotype and to control fluid volume and blood pressure more strictly in these patients to prevent future cardiac events.","PeriodicalId":17830,"journal":{"name":"Kidney Diseases","volume":"34 1","pages":"246 - 252"},"PeriodicalIF":3.2000,"publicationDate":"2021-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Echocardiographic Findings and Genotypes in Autosomal Dominant Polycystic Kidney Disease\",\"authors\":\"Ryohei Miyamoto, Akinari Sekine, T. Fujimaru, Tatsuya Suwabe, H. Mizuno, E. Hasegawa, M. Yamanouchi, Motoko Chiga, Takayasu Mori, E. Sohara, S. Uchida, N. Sawa, Y. Ubara, J. Hoshino\",\"doi\":\"10.1159/000520300\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary cystic kidney disease and is well known to have extrarenal complications. Cardiovascular complications are of particular clinical relevance because of their morbidity and mortality; however, unclear is why they occur so frequently in patients with ADPKD and whether they are related to the genotypes. Methods: We extracted and retrospectively analyzed clinical data on patients with ADPKD who underwent echocardiography and whose genotype was confirmed by genetic testing between April 2016 and December 2020. We used next-generation sequencing to compare cardiac function, structural data, and the presence of cardiac valvular disease in patients with 1 of 3 genotypes: PKD1, PKD2, and non-PKD1, 2. Results: This retrospective study included 65 patients with ADPKD. Patients were divided into 3 groups: PKD1, n = 32; PKD2, n = 12; and non-PKD1, 2, n = 21. The prevalence of mitral regurgitation (MR) was significantly higher in the PKD1 group than in the PKD2 and non-PKD1, 2 group (46.9% vs. 8.3% vs. 19.0%, respectively; p = 0.02). In contrast, no significant difference was found for other cardiac valve complications. Conclusion: This study found a significantly higher prevalence of MR in patients with the PKD1 genotype than in those with the PKD2 or non-PKD1, 2 genotypes. Physicians may need to perform echocardiography earlier and more frequently in patients with ADPKD and the PKD1 genotype and to control fluid volume and blood pressure more strictly in these patients to prevent future cardiac events.\",\"PeriodicalId\":17830,\"journal\":{\"name\":\"Kidney Diseases\",\"volume\":\"34 1\",\"pages\":\"246 - 252\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2021-11-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000520300\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000520300","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 5
摘要
背景:常染色体显性多囊肾病(ADPKD)是最常见的遗传性多囊肾病,通常有肾外并发症。心血管并发症因其发病率和死亡率而具有特殊的临床意义;然而,目前尚不清楚为什么它们在ADPKD患者中如此频繁地发生,以及它们是否与基因型有关。方法:我们提取并回顾性分析2016年4月至2020年12月期间接受超声心动图检查并经基因检测确认基因型的ADPKD患者的临床资料。我们使用新一代测序来比较3种基因型(PKD1、PKD2和非PKD1、2)中1种基因型患者的心功能、结构数据和心脏瓣膜疾病的存在。结果:本回顾性研究纳入65例ADPKD患者。患者分为3组:PKD1组,n = 32;PKD2, n = 12;非pkd1, 2, n = 21。PKD1组的二尖瓣反流(MR)发生率明显高于PKD2组和非PKD1, 2组(分别为46.9%、8.3%和19.0%;P = 0.02)。相比之下,其他心脏瓣膜并发症无显著差异。结论:本研究发现PKD1基因型患者MR患病率明显高于PKD2或非PKD1, 2基因型患者。对于患有ADPKD和PKD1基因型的患者,医生可能需要更早、更频繁地进行超声心动图检查,并更严格地控制这些患者的液量和血压,以防止未来发生心脏事件。
Echocardiographic Findings and Genotypes in Autosomal Dominant Polycystic Kidney Disease
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary cystic kidney disease and is well known to have extrarenal complications. Cardiovascular complications are of particular clinical relevance because of their morbidity and mortality; however, unclear is why they occur so frequently in patients with ADPKD and whether they are related to the genotypes. Methods: We extracted and retrospectively analyzed clinical data on patients with ADPKD who underwent echocardiography and whose genotype was confirmed by genetic testing between April 2016 and December 2020. We used next-generation sequencing to compare cardiac function, structural data, and the presence of cardiac valvular disease in patients with 1 of 3 genotypes: PKD1, PKD2, and non-PKD1, 2. Results: This retrospective study included 65 patients with ADPKD. Patients were divided into 3 groups: PKD1, n = 32; PKD2, n = 12; and non-PKD1, 2, n = 21. The prevalence of mitral regurgitation (MR) was significantly higher in the PKD1 group than in the PKD2 and non-PKD1, 2 group (46.9% vs. 8.3% vs. 19.0%, respectively; p = 0.02). In contrast, no significant difference was found for other cardiac valve complications. Conclusion: This study found a significantly higher prevalence of MR in patients with the PKD1 genotype than in those with the PKD2 or non-PKD1, 2 genotypes. Physicians may need to perform echocardiography earlier and more frequently in patients with ADPKD and the PKD1 genotype and to control fluid volume and blood pressure more strictly in these patients to prevent future cardiac events.
期刊介绍:
''Kidney Diseases'' aims to provide a platform for Asian and Western research to further and support communication and exchange of knowledge. Review articles cover the most recent clinical and basic science relevant to the entire field of nephrological disorders, including glomerular diseases, acute and chronic kidney injury, tubulo-interstitial disease, hypertension and metabolism-related disorders, end-stage renal disease, and genetic kidney disease. Special articles are prepared by two authors, one from East and one from West, which compare genetics, epidemiology, diagnosis methods, and treatment options of a disease.